ArticlePLoS pathogens2021

Nasal alum-adjuvanted vaccine promotes IL-33 release from alveolar epithelial cells that elicits IgA production via type 2 immune responses.

Eita Sasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.